TrialBreast cancer research and treatment2018

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

Amanda E D Van Swearingen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.